Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Inventory (2021 - 2025)

Mirum Pharmaceuticals (MIRM) has 5 years of Change in Inventory data on record, last reported at $2.3 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 966.36% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $8.4 million, up 166.84%, while the annual FY2025 figure was $8.4 million, 166.84% up from the prior year.
  • Change in Inventory reached $2.3 million in Q4 2025 per MIRM's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.8 million in Q3 2022 and bottomed at -$1.2 million in Q4 2023.
  • Average Change in Inventory over 5 years is $972411.8, with a median of $964000.0 recorded in 2024.
  • Peak YoY movement for Change in Inventory: tumbled 220.81% in 2022, then skyrocketed 1061.19% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $495000.0 in 2021, then crashed by 220.81% to -$598000.0 in 2022, then tumbled by 106.02% to -$1.2 million in 2023, then surged by 117.37% to $214000.0 in 2024, then surged by 966.36% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $2.3 million in Q4 2025, $1.2 million in Q3 2025, and $2.3 million in Q2 2025.